Introduction
Every September, Gynecologic Cancer Awareness shines a spotlight on cancers that affect the female reproductive system, including ovarian, cervical, uterine (endometrial), vaginal, and vulvar cancers. While these diseases differ in their causes and treatments, they share one important characteristic: early detection can significantly improve outcomes.
Gynecologic cancers account for hundreds of thousands of diagnoses worldwide each year. Cervical cancer alone affected an estimated 660,000 women and caused about 350,000 deaths globally in 2022, despite being one of the most preventable forms of cancer through HPV vaccination and regular screening.
Unlike many other cancers, gynecologic cancers often begin with symptoms that can easily be mistaken for less serious conditions. Understanding these warning signs—and acting on them—can make a critical difference.
How well do you know the symptoms your body may already be trying to tell you?
Five Cancers, Different Warning Signs
Gynecologic cancer is not a single disease. It includes five distinct cancers:
- Cervical cancer, which develops in the cervix and is strongly linked to persistent infection with high-risk human papillomavirus (HPV).
- Ovarian cancer, often called the “silent disease” because symptoms can be subtle during its early stages.
- Endometrial (uterine) cancer, the most common gynecologic cancer in many countries, frequently presenting with abnormal uterine bleeding.
- Vaginal cancer, a rare cancer affecting the vaginal tissues.
- Vulvar cancer, which develops on the external female genitalia and may cause persistent itching, pain, or skin changes.
Although each cancer has unique characteristics, recognizing unusual symptoms and seeking medical evaluation promptly are essential.
Common Gynecologic Cancer Signs
Many gynecologic cancers produce symptoms long before they become advanced. However, because these symptoms often overlap with common conditions, diagnosis may be delayed.
Warning signs include:
- abnormal vaginal bleeding, especially after menopause or between menstrual periods
- persistent pelvic or abdominal pain
- ongoing bloating or abdominal swelling
- difficulty eating or feeling full quickly
- frequent or urgent urination
- unusual vaginal discharge
- persistent itching, sores, or skin changes around the vulva
These symptoms do not automatically indicate cancer. However, if they persist for several weeks or become more frequent, they should be discussed with a healthcare professional.
Prevention and Early Detection Save Lives
Among gynecologic cancers, cervical cancer is unique because it is largely preventable.
Persistent infection with high-risk HPV causes approximately 99% of cervical cancer cases. HPV vaccination, combined with routine cervical screening, can detect precancerous changes before cancer develops.
To eliminate cervical cancer as a public health problem, the World Health Organization has established the 90-70-90 strategy:
- 90% of girls fully vaccinated against HPV by age 15.
- 70% of women screened by ages 35 and 45.
- 90% of women with precancer or invasive cancer receiving appropriate treatment.
Unfortunately, there are currently no routine population screening tests for ovarian, vulvar, vaginal, or endometrial cancers. This makes awareness of symptoms and timely medical evaluation even more important.
Research Is Changing the Future
Advances in medical research are transforming gynecologic cancer care. Artificial intelligence is helping improve the interpretation of cervical screening images, while genomic sequencing allows clinicians to identify genetic changes that guide personalized treatments. Researchers are also investigating liquid biopsies, blood-based biomarkers, and advanced imaging technologies that may enable earlier detection of ovarian and endometrial cancers.
These innovations aim to diagnose cancers sooner, improve treatment decisions, and reduce unnecessary procedures, offering hope for better outcomes in the future.
A One Health Perspective
Although gynecologic cancers are not infectious diseases, the One Health approach reminds us that health is shaped by many interconnected factors.
Access to preventive healthcare, HPV vaccination programs, environmental exposures, nutrition, socioeconomic conditions, and health education all influence cancer risk and outcomes. Addressing these broader determinants helps reduce disparities in diagnosis and treatment while improving women’s health across communities.
Collaboration among clinicians, researchers, public health professionals, educators, and policymakers continues to strengthen prevention strategies and expand access to lifesaving care.
Conclusion
Gynecologic cancers affect hundreds of thousands of women every year, yet many cases can be detected earlier through awareness, preventive care, and prompt medical evaluation.
This Gynecologic Cancer Awareness Month, take time to learn the warning signs, encourage conversations about women’s health, and support regular preventive care.
References
- International Agency for Research on Cancer (IARC) (2026) IARC marks Cervical Cancer Awareness Month 2026. Available at: https://www.iarc.who.int/news-events/iarc-marks-cervical-cancer-awareness-month-2026/
- Arbyn, M., Weiderpass, E., Bruni, L., de Sanjosé, S., Saraiya, M., Ferlay, J. and Bray, F. (2020) ‘Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis’, The Lancet Global Health, 8(2), pp. e191–e203. Available at:
https://doi.org/10.1016/S2214-109X(19)30482-6 - Sung, H., Ferlay, J., Siegel, R.L. et al. (2021) ‘Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries’, CA: A Cancer Journal for Clinicians, 71(3), pp. 209–249. Available at:
https://doi.org/10.3322/caac.21660 - Crosbie, E.J., Kitson, S.J., McAlpine, J.N., Mukhopadhyay, A., Powell, M.E. and Singh, N. (2022) ‘Endometrial cancer’, The Lancet, 399(10333), pp. 1412–1428. Available at:
https://doi.org/10.1016/S0140-6736(22)00323-3
